Cargando…
Cell-Free DNA as a Surveillance Tool for Hepatocellular Carcinoma Patients after Liver Transplant
SIMPLE SUMMARY: The liver is the world’s sixth most common primary tumor site, accountable for nearly 5% of all cancers and over 8% of cancer-related deaths. Hepatocellular carcinoma (HCC) is the predominant type of liver cancer, accounting for about 75% of all primary liver tumors. One of the major...
Autores principales: | Manzi, Joao, Hoff, Camilla O., Ferreira, Raphaella, Glehn-Ponsirenas, Renata, Selvaggi, Gennaro, Tekin, Akin, O’Brien, Christopher B., Feun, Lynn, Vianna, Rodrigo, Abreu, Phillipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296050/ https://www.ncbi.nlm.nih.gov/pubmed/37370775 http://dx.doi.org/10.3390/cancers15123165 |
Ejemplares similares
-
Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives
por: Manzi, Joao, et al.
Publicado: (2023) -
Liver Inclusion Appears to Be Protective Against Graft Loss-Due-to Chronic But Not Acute Rejection Following Intestinal Transplantation
por: Vianna, Rodrigo, et al.
Publicado: (2023) -
No Benefit of Prophylactic Surgical Drainage in Combined Liver and Kidney Transplantation: Our Experience and Review of the Literature
por: Vincenzi, Paolo, et al.
Publicado: (2021) -
Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring
por: Ponsirenas, Renata von Glehn, et al.
Publicado: (2018) -
A Less Restrictive Policy for Liver Transplantation in Coronavirus Disease 2019 Positive Patients, Based Upon Cycle Threshold Values
por: Raveh, Yehuda, et al.
Publicado: (2021)